Adial Pharmaceuticals Inc ADIL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:16 PM EDT
4.27quote price arrow up+0.15 (+3.64%)
Volume
58,664
52 week range
1.14 - 4.78
Loading...
  • Open4.16
  • Day High4.27
  • Day Low4.10
  • Prev Close4.12
  • 52 Week High4.78
  • 52 Week High Date09/07/21
  • 52 Week Low1.14
  • 52 Week Low Date09/24/20

Key Stats

  • Market Cap86.68M
  • Shares Out20.30M
  • 10 Day Average Volume0.36M
  • Dividend-
  • Dividend Yield-
  • Beta0.73
  • YTD % Change150

KEY STATS

  • Open4.16
  • Day High4.27
  • Day Low4.10
  • Prev Close4.12
  • 52 Week High4.78
  • 52 Week High Date09/07/21
  • 52 Week Low1.14
  • 52 Week Low Date09/24/20
  • Market Cap86.68M
  • Shares Out20.30M
  • 10 Day Average Volume0.36M
  • Dividend-
  • Dividend Yield-
  • Beta0.73
  • YTD % Change150

RATIOS/PROFITABILITY

  • EPS (TTM)-1.04
  • P/E (TTM)-4.10
  • Fwd P/E (NTM)-5.51
  • EBITDA (MRQ)-16.05M
  • ROE (MRQ)-236.09%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/14/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Adial Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Adial Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of medications for the treatment of addictions and related disorders. Its lead investigational drug product is AD04. AD04 is being developed for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist. AD04 is being designed to be used for the treatment of other addictive disorders, such as opioid use...
Kevin Schuyler
Vice Chairman
William Stilley III
President
Joseph Truluck
Chief Financial Officer
Address
1180 SEMINOLE TRAIL, SUITE 495
Charlottesville, VA
22901
United States

Top Peers

SYMBOLLASTCHG%CHG
GLMD
Galmed Pharmaceuticals Ltd
2.83-0.05-1.74%
IMRA
Imara Inc
4.20+0.01+0.12%
ACHV
Achieve Life Sciences Inc
8.06+0.14+1.78%
SLNO
Soleno Therapeutics Inc
0.9044+0.0094+1.05%
MTCR
Metacrine, Inc.
3.10+0.09+2.99%